SCHEMBL1781130

SCHEMBL1781130

COCCON=Cc1ccc(N(NC(=O)OC(C)(C)C)C(=O)O)cc1

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.46
NPC1 O15118 4/20 0.46
MAPT P10636 4/20 0.46
RAB9A P51151 3/20 0.46
ALDH1A1 P00352 3/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
MIF P14174 1/20 0.40
RECQL P46063 2/20 0.39
MEN1 O00255 4/20 0.39
KMT2A Q03164 4/20 0.39
POLB P06746 2/20 0.39
LMNA P02545 2/20 0.36
HDAC1 Q13547 1/20 0.36
HDAC2 Q92769 1/20 0.36
AKT1 P31749 2/20 0.35
ATM Q13315 1/20 0.35
CCNO P22674 1/20 0.34
GAA P10253 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1781128 0.92 KDM4E (0.45) KDM4ENPC1MAPTRAB9AALDH1A1
SCHEMBL4550804 0.92 KDM4E (0.45) KDM4ENPC1MAPTRAB9AALDH1A1
SCHEMBL1785421 0.81 HDAC3 (0.56) KDM4ENPC1MAPTRAB9AALDH1A1
SCHEMBL1781295 0.77 RAB9A (0.47) KDM4ENPC1MAPTRAB9AALDH1A1
SCHEMBL4550452 0.77 KDM4E (0.32) KDM4ENPC1MAPTRAB9A
SCHEMBL10182754 0.75 KDM4E (0.31) KDM4ENPC1MAPTRAB9APOLB
SCHEMBL1785419 0.74 HDAC3 (0.56) KDM4ENPC1MAPTRAB9AALDH1A1
SCHEMBL4550903 0.74 HDAC3 (0.56) KDM4ENPC1MAPTRAB9AALDH1A1
SCHEMBL1780465 0.70 AKT1 (0.41) KDM4ENPC1MAPTRAB9ASMN1; SMN2
SCHEMBL28974600 0.70 MAPT (0.41) KDM4ENPC1MAPTRAB9AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8304556-B2 Thiazolyl-dihydro-indazoles BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-11-06 US disclosed
US-20120108567-A1 Thiazolyl-Dihydro-Indazoles BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-05-03 US disclosed
US-20110118208-A1 Thiazolyl-Dihydro-Indazoles BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2011-05-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120108567-A1 Thiazolyl-Dihydro-Indazoles MKI67, CYP11B1, IGF1R KDM4E 3045/4885NPC1 136/4885MAPT 2509/4885
US-20110118208-A1 Thiazolyl-Dihydro-Indazoles MKI67, CYP11B1, IGF1R KDM4E 3045/4885NPC1 136/4885MAPT 2509/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.